Monday, 23 September 2019

Japan News

  • Novartis under fire from Tasigna allegations

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 14 May, 2014

    Singapore: Swiss giant Novartis Pharma's Japanese arm has prompted the Japanese health ministry to launch an investigation under possible violation of the pharmaceutical affairs law. It has...Read more

  • Genmab in research deal with Kyowa Hakko Kirin

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 07 Dec, 2012

    Singapore: Genmab has entered into a research collaboration with Japan-based Kyowa Hakko Kirin to create bispecific antibodies using Genmab's DuoBody technology. If successful, the parties ...Read more

  • Japanese-Thai program to fund three projects

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 27 Jul, 2012

    Singapore: Japan Science and Technology Agency (JST) and the National Science and Technology Development Agency (NSTDA) have developed a scheme for joint funding of Japanese-Thai cooperativ...Read more

  • Daiichi seeks approval for influenza antiviral in Japan

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 19 Nov, 2012

    Singapore: Daiichi Sankyo has submitted an application for a partial label change in Japan to manufacture and market the influenza antiviral product Inavir Dry Powder Inhaler (laninamivir o...Read more

  • Mitsubishi and Daiichi Sankyo to launch diabetes drug in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 28 Aug, 2012

    Singapore: Mitsubishi Tanabe Pharma and Daiichi Sankyo will launch selective DPP-4 inhibitor Tenelia 20mg tablets (teneligliptin hydrobromide hydrate tablets) in Japan on September 10, 2012...Read more

  • Pic Gallery - 7th in-Pharma Japan and 26th Interphex Japan

    Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 05 Aug, 2013

    7th in-Pharma Japan and 26th Interphex Japan, which was held from July 10-12, 2013, at Tokyo Big Sight, Japan...Read more

  • Pharma companies focus on supply chain in Japan

    Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 19 Jul, 2012

    Singapore: Pressures felt in Japan as a result of the country's aging population, drug price revisions and patent expiries have compelled pharmaceutical industry leaders to rationalize thei...Read more

  • Takeda subsidiary suspended for 'no drug label'

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 20 Feb, 2013

    Singapore: Takeda Pharmaceutical received an Order for Corrective Action regarding the manufacturing and marketing of Alinamin-F5 Injection from the Osaka Prefectural Government, citing a v...Read more

  • Thermo Fisher enters into agreement Fujirebio

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 21 Nov, 2012

    Singapore: Thermo Fisher Scientific signed a long-term license agreement with Fujirebio to make its biomarker assay Procalcitonin (PCT) available on the Lumipulse family of laboratory ins...Read more

  • Bayer colorectal cancer drug gets Japanese nod

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 26 Mar, 2013

    Singapore: Japan's Ministry of Health, Labor and Welfare (MHLW) has approved Bayer HealthCare and Onyx Pharmaceuticals's Stivarga (regorafenib) tablets for the treatment of patients with me...Read more

  • Astellas, Ambit terminate cancer drug deal

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 12 Mar, 2013

    Singapore: Japan-based Astellas Pharma and US-headquartered Ambit Biosciences are ending their collaboration for joint development and commercialization of FMS-like tyrosine kinase-3 (FLT3)...Read more

  • Edison Pharma, DSP enter $4 bn metablosim drug deal

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 04 Feb, 2014

    Singapore: US-based Edison Pharmaceuticals has entered into a strategic alliance valued up to $4.295 billion with Japan's Dainippon Sumitomo Pharma (DSP) for the development of drugs target...Read more

  • Gilead files NDA for Hep C drug in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jun, 2014

    Singapore: US-based Gilead Sciences has submitted a New Drug Application (NDA) to Japan's Pharmaceutical and Medical Devices Agency (PMDA) for approval of sofosbuvir, a once-daily nucleotid...Read more

  • AnGes, Mitsubishi Tanabe sign MoU to market Collategene

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 29 Oct, 2012

    Singapore: AnGes MG entered into a definitive agreement with Mitsubishi Tanabe Pharma for the exclusive marketing rights of Collategene (DNA plasmid with HGF gene) as a treatment for peri...Read more

  • What the future holds for the APAC CRO market?

    Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

    The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

  • Japan scientists pioneer new stem cell technology

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2012

    Singapore: A research team at the tissue regeneration materials unit, National Institute for Materials Science (NIMS), succeeded in fabricating two types of cell matrix materials that mimic...Read more

  • Astellas gets FDA nod for kidney transplant drug

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 22 Jul, 2013

    Singapore: Japan-based Astellas Pharma has received US FDA approval for Astagraf XL (tacrolimus extended-release capsules) for the prophylaxis of organ rejection in patients receiving a kid...Read more

  • Global collaborations is the way forward for drug discovery

    Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 19 Dec, 2012

    Over the last few decades India has reiterated its capabilities in providing dependable and cost effective chemistry services to big pharma through a multitude of outsourcing deals. A large...Read more



Podcast

 

Survey Box

Is Pharma innovation getting inhibited in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls